ERCC1 and cervical carcinoma: In this review, ERCC1 expression was found to be correlated to chemotherapy-resistance (i.e., cisplatin and 5-FU) in cervical carcinoma, chemotherapy combined with ERCC1 inhibitor may dramatically reduce the immunosuppression and thus reinstate the immune function.